Sofia C Tortora

Dr. Sofia C Tortora

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in The Journal of Prosthetic Dentistry
Verified
Journal Article
Closed access
EMEduardo Mahn
Eduardo Mahn
STSofia C Tortora
Sofia C Tortora
BOBarbara Olate
Barbara Olate
FCFranco Cacciuttolo
Franco Cacciuttolo
JKJeremy Kernitsky
Jeremy Kernitsky
GJGilbert Jorquera
Gilbert Jorquera

21 October 2024 in Cancers
Verified
Journal Article
Open access
PDF file
MAMaria Gonzalez Agurto
Maria Gonzalez Agurto
NONicolas Olivares
Nicolas Olivares
GCGisela Canedo-Marroquin
Gisela Canedo-Marroquin
DEDaniela Espinoza
Daniela Espinoza
STSofia C Tortora
Sofia C Tortora
Head and neck cancers (HNCs) are the seventh most common cancer worldwide, accounting for 4–5% of all malignancies. Salivary metabolites, which serve as key metabolic intermediates and cell-signalling molecules, are emerging as potential diagnostic biomarkers for HNC. While current research has largely concentrated on these metabolites as biomarkers, a critical gap remains in understanding their fluctuations before and after treatment, as well as their involvement in oral side effects. Recent studies emphasise the role of the oral microbiome and its metabolic activity in cancer progression and treatment efficacy by bacterial metabolites and virulence factors. Oral bacteria, such as P. gingivalis and F. nucleatum, contribute to a pro-inflammatory environment that promotes tumour growth. Additionally, F. nucleatum enhances its virulence through flagellar assembly and iron transport mechanisms, facilitating tumour invasion and survival. Moreover, alterations in the oral microbiome can influence chemotherapy efficacy and toxicity through the microbiota–host irinotecan axis, highlighting the complex interplay between microbial communities and therapeutic outcomes. Salivary metabolite profiles are influenced by factors such as gender, methods, and patient habits like smoking—a major risk factor for HNC. Radiotherapy (RT), a key treatment for HNC, often causes side effects such as xerostomia, oral mucositis, and swallowing difficulties which impact survivors’ quality of life. Intensity-modulated radiotherapy (IMRT) aims to improve treatment outcomes and minimise side effects but can still lead to significant salivary gland dysfunction and associated complications. This review underscores the microbial and host interactions affecting salivary metabolites and their implications for cancer treatment and patient outcomes.

13 September 2019 in Journal of Esthetic and Restorative Dentistry
Verified
Journal Article
Closed access
PDF file
BSBruno P. Silva
Bruno P. Silva
STSofia C Tortora
Sofia C Tortora
KSKyle Stanley
Kyle Stanley
GMGustavo Mahn
Gustavo Mahn
CCChristian Coachman
Christian Coachman
EMEduardo Mahn
Eduardo Mahn

28 March 2026 in medRxiv
Verified
Preprint
Open access
MKMelissa Kramer
Melissa Kramer
PBPascal Belleau
Pascal Belleau
STSofia C Tortora
Sofia C Tortora
ADAstrid Deschenes
Astrid Deschenes
KFKyriaki Founta
Kyriaki Founta
LMLaura A. Martello
Laura A. Martello
Colorectal cancer (CRC) incidence, tumor biology, and clinical outcomes differ by patient ancestry, yet African ancestry (AFR) populations remain underrepresented in genomic and microbiome studies. Here, we comprehensively characterized genomic, transcriptomic and microbiome features of AFR and European ancestry (EUR) colon cancer patients residing in New York City and Long Island. While confirming known drivers from other large CRC studies, our AFR to EUR comparison of somatic variation also revealed a possible enrichment of functional KRAS variants in AFR tumors. Colon cancer genomes in patients in this study also exhibit distinct patterns of DNA copy number variation, correlating with consensus molecular subtypes. Fusobacterium nucleatum-positive tumors were enriched for co-occurring oral taxa, suggesting an organized oral microbial structure within the tumor microenvironment. Our findings highlight ancestry-associated differences in somatic mutation, copy number variation, and tumor microbiome composition, underscoring the urgent need to expand AFR representation in genomic studies to uncover population-specific determinants of CRC risk and to develop treatment strategies that reflect the full diversity of patients affected by this disease.